{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:29:34Z","timestamp":1788172174453,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3591,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>To address the current role of liver transplantation (LT) for urea cycle disorders (UCDs), we reviewed the worldwide English literature on the outcomes of LT for UCD as well as 13 of our own cases of living donor liver transplantation (LDLT) for UCD. The total number of cases was 51, including our 13 cases. The overall cumulative patient survival rate is presumed to be more than 90% at 5 years. Most of the surviving patients under consideration are currently doing well with satisfactory quality of life. One advantage of LDLT over deceased donor liver transplantation (DDLT) is the opportunity to schedule surgery, which beneficially affects neurological consequences. Auxiliary partial orthotopic liver transplantation (APOLT) is no longer considered significant for the establishment of gene therapies or hepatocyte transplantation but plays a significant role in improving living liver donor safety; this is achieved by reducing the extent of the hepatectomy, which avoids right liver donation. Employing heterozygous carriers of the UCDs as donors in LDLT was generally acceptable. However, male hemizygotes with ornithine transcarbamylase deficiency (OTCD) must be excluded from donor candidacy because of the potential risk of sudden-onset fatal hyperammonemia. Given this possibility as well as the necessity of identifying heterozygotes for other disorders, enzymatic and\/or genetic assays of the liver tissues in cases of UCDs are essential to elucidate the impact of using heterozygous carrier donors on the risk or safety of LDLT donor-recipient pairs. In conclusion, LT should be considered to be the definitive treatment for UCDs at this stage, although some issues remain unresolved. (Liver Transpl 2005;11:1332\u20131342.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20587","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T13:42:53Z","timestamp":1129815773000},"page":"1332-1342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":133,"title":["Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University"],"prefix":"10.1097","volume":"11","author":[{"given":"Daisuke","family":"Morioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutsugu","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Uryuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-9-20250124","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.ymgme.2003.08.027","article-title":"The role of liver transplantation in urea cycle disorders.","volume":"81","author":"Leonard","year":"2004","journal-title":"Molecul Genet Metabol"},{"issue":"Suppl 1","key":"R4-9-20250124","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1023\/A:1005317909946","article-title":"Liver transplantation for the treatment of urea cycle disorders.","volume":"21","author":"Whitington","year":"1998","journal-title":"J Inherit Metab Dis"},{"key":"R5-9-20250124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3476(89)80843-1","article-title":"Liver transplantation for ornithine transcarbamylase deficiency in a girl.","volume":"115","author":"Largilliere","year":"1989","journal-title":"J Pediatr"},{"key":"R6-9-20250124","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM198906013202219","article-title":"Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency.","volume":"320","author":"Tuchman","year":"1989","journal-title":"N Engl J Med"},{"key":"R7-9-20250124","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00000658-199009000-00015","article-title":"Application of reducedsize liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants.","volume":"212","author":"Broelsch","year":"1990","journal-title":"Ann Surg"},{"key":"R8-9-20250124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840150311","article-title":"Orthotopic liver transplantation for urea cycle enzyme deficiency.","volume":"15","author":"Todo","year":"1992","journal-title":"Hepatology"},{"key":"R9-9-20250124","first-page":"188","article-title":"Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases.","volume":"26","author":"Jan","year":"1994","journal-title":"Transplant Proc"},{"key":"R10-9-20250124","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0022-3468(95)90766-1","article-title":"Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy.","volume":"30","author":"Hasegawa","year":"1995","journal-title":"J Pediatr Surg"},{"key":"R11-9-20250124","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-0012.1997.tb00851.x","article-title":"Orthotopic liver transplantation for adultonset type II citrullinemia.","volume":"11","author":"Kawamoto","year":"1997","journal-title":"Clin Transpl"},{"key":"R12-9-20250124","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/lt.500040504","article-title":"The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.","volume":"4","author":"Busuttil","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"R13-9-20250124","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1005561509704","article-title":"Liver transplantation for citrullinemia improves intellectual function.","volume":"22","author":"Fletcher","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"R14-9-20250124","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2169\/internalmedicine.39.553","article-title":"Type II citrullinemia in an elderly patient treated with living related partial liver transplantation.","volume":"39","author":"Takenaka","year":"2000","journal-title":"Intern Med"},{"key":"R15-9-20250124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007890-200101150-00027","article-title":"Livingrelated liver transplantation for type II citrullinemia using a graft from heterozygote donor.","volume":"71","author":"Kasahara","year":"2001","journal-title":"Transplantation"},{"key":"R16-9-20250124","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00007890-200105270-00026","article-title":"A pediatric patient with classical citrullinemia who underwent livingrelated partial liver transplantation.","volume":"71","author":"Ban","year":"2001","journal-title":"Transplantation"},{"key":"R17-9-20250124","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1013960712516","article-title":"Liver transplantation in a case of argininaemia.","volume":"24","author":"Santos Silva","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R18-9-20250124","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/jnnp.71.5.663","article-title":"Type II (adult onset) citrullinemia: clinical pictures and the therapeutic effect of liver transplantation.","volume":"71","author":"Ikeda","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-9-20250124","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00431-002-1045-2","article-title":"Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation.","volume":"161","author":"Tamamori","year":"2002","journal-title":"Eur J Pediatr"},{"key":"R20-9-20250124","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lt.20131","article-title":"Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adultonset type II citrullinemia.","volume":"10","author":"Yazaki","year":"2004","journal-title":"Liver Transpl"},{"key":"R21-9-20250124","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1542\/peds.2004-0198","article-title":"Developmental outcomes with early orthotopic liver transplantation for infants with neonatalonset ornithine transcarbamylase deficiency.","volume":"114","author":"McBride","year":"2004","journal-title":"Pediatrics"},{"key":"R22-9-20250124","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00007890-199704150-00021","article-title":"Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency.","volume":"63","author":"Uemoto","year":"1997","journal-title":"Transplantation"},{"key":"R23-9-20250124","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0022-3468(98)90278-0","article-title":"Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a livingdonor program.","volume":"33","author":"Kasahara","year":"1998","journal-title":"J Pediatr Surg"},{"key":"R24-9-20250124","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jpedsurg.2004.03.079","article-title":"Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease.","volume":"39","author":"Kasahara","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R25-9-20250124","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199006073222305","article-title":"Allopurinolinduced orotiduria. A test for mutations at the ornithine carbamoyltransferase locus in women.","volume":"322","author":"Hauser","year":"1990","journal-title":"N Engl J Med"},{"key":"R26-9-20250124","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/clinchem\/45.7.995","article-title":"Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.","volume":"45","author":"Arranz","year":"1999","journal-title":"Clin Chem"},{"key":"R27-9-20250124","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1432-2277.1996.tb00881.x","article-title":"Guidelines for donor selection and an overview of the donor operation in living related liver transplantation.","volume":"9","author":"Morimoto","year":"1996","journal-title":"Transpl Int"},{"key":"R28-9-20250124","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1432-2277.2000.tb01006.x","article-title":"Hepatic grafts from live donors: donor morbidities for 470 cases of liver donation.","volume":"13","author":"Fujita","year":"2000","journal-title":"Transpl Int"},{"key":"R29-9-20250124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/9667","article-title":"The gene mutated in adultonset type II citrullinemia encodes a putative mitochondrial carrier protein.","volume":"22","author":"Kobayashi","year":"1999","journal-title":"Nat Genet"},{"key":"R31-9-20250124","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00431-002-1126-2","article-title":"Hyperammonaemia as a cause of psychosis in an adolescent.","volume":"162","author":"BelangerQuintana","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R32-9-20250124","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/01.TP.0000079446.94204.F9","article-title":"Livingdonor liver transplantation with monosegments.","volume":"76","author":"Kasahara","year":"2003","journal-title":"Transplantation"},{"key":"R33-9-20250124","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/lt.20179","article-title":"Advances in adult living donor liver transplantation: a review based on reports from the 10th anniversary of the adulttoadult living donor liver transplantation meeting in Tokyo.","volume":"10","author":"Sugawara","year":"2004","journal-title":"Liver Transpl"},{"issue":"Suppl 9","key":"R34-9-20250124","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1053\/jlts.2003.50198","article-title":"Smallforsize graft in living donor liver transplantation: how far should we go?","volume":"9","author":"Kiuchi","year":"2003","journal-title":"Liver Transpl"},{"key":"R35-9-20250124","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.TP.0000072372.42396.47","article-title":"Surgeryrelated morbidity in living donors of rightlobe liver graft: lessons from the first 200 cases.","volume":"76","author":"Ito","year":"2003","journal-title":"Transplantation"},{"key":"R36-9-20250124","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.TP.0000115342.98226.7C","article-title":"The first donor death after livingrelated liver transplantation in Japan.","volume":"77","author":"Akabayashi","year":"2004","journal-title":"Transplantation"},{"key":"R37-9-20250124","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1053\/jlts.2002.36844","article-title":"Gene therapy as an alternative to liver transplantation.","volume":"8","author":"Kren","year":"2002","journal-title":"Liver Transpl"},{"key":"R38-9-20250124","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s001090100260","article-title":"Hepatocyte transplantation: clinical and experimental application.","volume":"79","author":"Ohashi","year":"2001","journal-title":"J Mol Med"},{"key":"R39-9-20250124","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-6143.2005.00717.x","article-title":"Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience.","volume":"5","author":"Kasahara","year":"2005","journal-title":"Am J Transplant"},{"key":"R40-9-20250124","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM199909163411214","article-title":"Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency.","volume":"341","author":"Plochl","year":"1999","journal-title":"N Engl J Med"},{"key":"R41-9-20250124","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1034\/j.1399-0004.1998.5440415.x","article-title":"Xinactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency.","volume":"54","author":"Yorifuji","year":"1998","journal-title":"Clin Genet"},{"issue":"Suppl 2","key":"R42-9-20250124","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/lt.20272","article-title":"Selection of pediatric candidates under the PELD system.","volume":"10","author":"McDiarmid","year":"2004","journal-title":"Liver Transpl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20587","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200511000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:04:40Z","timestamp":1737734680000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200511000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20587","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}